Multinationals get health PPP fever

Multinationals get health PPP fever

Although legal issues remain in some areas, public-private collaboration continues to be a focus among multinational corporations in Vietnam’s healthcare sector, and further expansions are being sought.
Sanofi unveils new corporate brand and logo

Sanofi unveils new corporate brand and logo

Sanofi unveiled a new bold and unifying corporate brand that supports the modernisation and transformation the company launched in December 2019.
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK on February 23 announced that they intend to submit data from both their booster and phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccines.
Sanofi Vietnam signs MoU with BSB Nanotech to create circular economy for rice husks

Sanofi Vietnam signs MoU with BSB Nanotech to create circular economy for rice husks

Sanofi Vietnam signed an MoU with BSB Nanotech to develop a new model of circular economy through the “Rice is the new green” sustainability project.
Multinationals grasp incentives

Multinationals grasp incentives

A number of multinational corporations are planning to venture further into local production to enjoy incentives and to benefit from the landmark EU-Vietnam Free Trade Agreement.
Sanofi reinforces presence in Vietnam

Sanofi reinforces presence in Vietnam

The presence of Prime Minister Pham Minh Chinh and the high-level Vietnamese government delegation at the signing ceremony of Vietnam Pharmaceutical Corporation (Vinapharm) and Sanofi’s cooperation..
Senior management board of Sanofi Vietnam awared Vietnam Excellence award

Senior management board of Sanofi Vietnam awared Vietnam Excellence award

Four senior leaders of Sanofi Vietnam have been recognised at the prestigious Vietnam Excellence awards for their success in transforming business.
Sanofi promotes environmental initiatives in Vietnam

Sanofi promotes environmental initiatives in Vietnam

Sanofi Vietnam and GIZ signed an agreement on cooperation in implementing the "Rice is the new green" project.
Bringing out the best in people at Sanofi

Bringing out the best in people at Sanofi

Driven by people-centric business administration, Sanofi is bringing out the best in its people and helping improve people’s accessibility to vaccines worldwide.
Sanofi’s ambition to empower lives

Sanofi’s ambition to empower lives

Amid the continuous development of COVID-19 globally, French drugmaker Sanofi is seeking to fulfil its ambition of empowering people this year and beyond.
Popular pharma products withdrawn by multinationals

Popular pharma products withdrawn by multinationals

Multinationals like Sanofi, GSK, Adamed Pharma, and Merck Sharp & Dohme have requested marketing authorisation withdrawal of some pharmaceuticals, with it being unclear if the quality of some popular items is an underlying issue.
Digitalisation prompts evolution of healthcare

Digitalisation prompts evolution of healthcare

Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
Vaccine sales stir big pharma

Vaccine sales stir big pharma

Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
Sanofi makes second run for EU-GMP recognition

Sanofi makes second run for EU-GMP recognition

Amid ongoing revision of the regulation of drug tenders at public hospitals, multinational corporations are renewing efforts to have EU-GMP standards for their manufacturing sites acknowledged in Vietnam to qualify for the most lucrative tenders.
Sanofi eyes approval of COVID-19 vaccine by first half of 2021

Sanofi eyes approval of COVID-19 vaccine by first half of 2021

PARIS: French drugmaker Sanofi said on Tuesday (Jun 23) it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year, faster than previously anticipated.
1 2